Minimal Residual Disease Surveillance in Chronic Lymphocytic Leukemia by Fluorescence-Activated Cell Sorting

por Ringelstein-Harlev, Shimrit, Fineman, Riva
Publicado 2014

ERK Activity in Immature Leukemic Cells Drives Clonal Selection during Induction Therapy for Acute Myeloid Leukemia

por Hayun, Michal, Zaatra, Maria, Itzkovich, Chen, Sahar, Dvora, Rosenberg, Dina, Filatova, Margarita, Ringelstein-Harlev, Shimrit, Baris, Hagit, Moustafa-Hawash, Nivin, Louria-Hayon, Igal, Ofran, Yishai
Publicado 2020

Third BNT162b2 mRNA SARS-CoV-2 Vaccine Dose Significantly Enhances Immunogenicity in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation

por Henig, Israel, Isenberg, Jonathan, Yehudai-Ofir, Dana, Leiba, Ronit, Ringelstein-Harlev, Shimrit, Ram, Ron, Avni, Batia, Amit, Odelia, Grisariu, Sigal, Azoulay, Tehila, Slouzkey, Ilana, Zuckerman, Tsila
Publicado 2023

Humoral serological response to the BNT162b2 vaccine is abrogated in lymphoma patients within the first 12 months following treatment with anti-CD2O antibodies

por Gurion, Ronit, Rozovski, Uri, Itchaki, Gilad, Gafter-Gvili, Anat, Leibovitch, Chiya, Raanani, Pia, Ben-Zvi, Haim, Szwarcwort, Moran, Taylor-Abigadol, Mor, Dann, Eldad J., Horesh, Nurit, Inbar, Tsofia, Tzoran, Inna, Lavi, Noa, Fineman, Riva, Ringelstein-Harlev, Shimrit, Horowitz, Netanel A.
Publicado 2021